These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27123083)

  • 1. Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma
    Jiang J; Yi BO; Ding S; Sun J; Cao W; Liu M
    Oncol Lett; 2016 May; 11(5):3167-3172. PubMed ID: 27123083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quaking I-5 protein inhibits invasion and migration of kidney renal clear cell carcinoma via inhibiting epithelial-mesenchymal transition suppression through the regulation of microRNA 200c.
    Zhang R; Wang W; Aimudula A; Lu S; Lu P; Aihaiti R; Bao Y
    Transl Androl Urol; 2021 Oct; 10(10):3800-3814. PubMed ID: 34804823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma
    Jiang J; Yi B; Ding S; Sun J; Cao W; Liu M
    Oncol Lett; 2021 Sep; 22(3):662. PubMed ID: 34386084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
    Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.
    Liu F; Wu L; Wang A; Xu Y; Luo X; Liu X; Hua Y; Zhang D; Wu S; Lin T; He D; Wei G; Chen S
    Am J Transl Res; 2017; 9(8):3611-3622. PubMed ID: 28861152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma.
    Čugura T; Boštjančič E; Uhan S; Hauptman N; Jeruc J
    Exp Mol Pathol; 2024 Jun; 138():104909. PubMed ID: 38876079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
    Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
    Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
    Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
    Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
    Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
    J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition.
    Shao XL; Chen Y; Gao L
    Int J Ophthalmol; 2017; 10(8):1195-1202. PubMed ID: 28861342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro.
    Wu A; Wu K; Li M; Bao L; Shen X; Li S; Li J; Yang Z
    Mol Med Rep; 2015 Jul; 12(1):1413-20. PubMed ID: 25815441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
    Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
    PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200c suppresses tumor metastasis in oral squamous carcinoma by inhibiting epithelial-mesenchymal transition.
    Xie NN; Liu ZX; Wu C; Wang PL; Song GT; Chen Z
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3415-3422. PubMed ID: 29917193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer.
    Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X
    Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pan H; Hong Y; Yu B; Li L; Zhang X
    Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.
    Koo T; Cho BJ; Kim DH; Park JM; Choi EJ; Kim HH; Lee DJ; Kim IA
    Oncotarget; 2017 Sep; 8(39):65457-65468. PubMed ID: 29029445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma.
    Wang X; Chen X; Han W; Ruan A; Chen L; Wang R; Xu Z; Xiao P; Lu X; Zhao Y; Zhou J; Chen S; Du Q; Yang H; Zhang X
    Mol Cancer Res; 2015 Dec; 13(12):1567-77. PubMed ID: 26248649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.